Search

Your search keyword '"Mark Geyer"' showing total 184 results

Search Constraints

Start Over You searched for: Author "Mark Geyer" Remove constraint Author: "Mark Geyer"
184 results on '"Mark Geyer"'

Search Results

1. Combining targeted and systematic prostate biopsy improves prostate cancer detection and correlation with the whole mount histopathology in biopsy naïve and previous negative biopsy patients

2. Prospective assessment of psychophysiological risk factors for PTSD

3. NCCN Guidelines® Insights: Hematopoietic Growth Factors, Version 1.2022

4. Mechanisms of Resistance to Noncovalent Bruton’s Tyrosine Kinase Inhibitors

5. Combining targeted and systematic prostate biopsy improves prostate cancer detection and correlation with the whole mount histopathology in biopsy naïve and previous negative biopsy patients

6. Abstract 10135: Cardiotoxicity and Mortality in Chimeric Antigen Receptor T Cell Therapy Recipients

8. Cognitive deficits associated with combined HIV gp120 expression and chronic methamphetamine exposure in mice

9. Adenovirus infection in paediatric allogeneic stem cell transplantation recipients is a major independent factor for significantly increasing the risk of treatment related mortality

10. Dementias and Other Amnestic Disorders

11. Discriminative-Cue-Induced Reinstatement

12. Drug Occasion Setter

13. Delusional Halitosis

14. Defensive Behaviors

15. Dimorphone

16. DNA Methyltransferase Inhibitors

17. Deficit Symptoms Syndrome

18. Drug Preferences

19. Drug Stimuli

20. Dietary Tryptophan Depletion

21. l-3,4-Dihydroxyphenylalanine

22. Discriminative Cue

23. DF-118

24. Decision Making

25. Drug-Induced Motor Syndromes

26. Declarative and Non-Declarative Memory

27. Deep Brain Stimulation

28. Drug Toxicity

29. Δ9-Tetrahydrocannabinol

30. Drug Addiction

31. Drugs as States

32. N,N Dimethyl-2[α-(o-Tolyl)Benzyloxy]Ethylamine HCl or Citrate

33. Drug Taste Preference Conditioning

34. Drug Effects

35. Delayed Match-to-Sample Test

36. Drug Interactions

37. Drug as Cues

38. Drug Vulnerability

39. Drug Discontinuation

40. Dopamine-and-Cyclic-AMP-Regulated-32KDa-Phosphoprotein

41. Defensive Responses

42. Drug Facilitator

43. Depression: Animal Models

44. Dopamine Reward Systems

45. Dominant Negative Antagonist

46. Delay Discounting Paradigms

47. Digital EEG Nomenclature

48. 1,3-Dihydro-7-Nitro-5-Phenyl-2H-1,4-Benzodiazepin-2-One

49. Delusions of Infestation

50. Disruptive Behavior Disorders

Catalog

Books, media, physical & digital resources